A New Therapeutic Paradigm
A therapeutic paradigm based on controlling systemic metabolic state to treat disease. Not a single target. Not a single pathway. The metabolic operating system itself.
Modern medicine treats diseases as isolated molecular events. A mutation drives cancer. A misfolded protein causes neurodegeneration. An autoimmune response triggers inflammation. Each disease gets its own target, its own drug, its own clinical pipeline.
But beneath these distinct pathologies lies a shared substrate: cellular energy metabolism. Every cell in the body depends on a continuous supply of ATP to maintain structure, execute functions, and respond to stress. When bioenergetic capacity fails, disease follows.
Metabolic State Medicine is the therapeutic paradigm built on this insight. Rather than targeting individual molecular lesions, it asks: can we control the systemic metabolic state of the organism to shift cellular bioenergetics in a direction that opposes disease?
The primary tool is pharmacological ketosis: sustained elevation of circulating ketone bodies through exogenous ketone ester therapeutics. Elevating BHB to therapeutic concentrations (1–5 mM) alters mitochondrial function, modulates inflammation, shifts redox balance, and activates neuroprotective gene expression programs. This is not a dietary intervention. This is pharmacological control of metabolic state with the precision, reproducibility, and scalability required for modern medicine.
Cross-Disease Platform
Bioenergetic dysfunction appears across diseases conventionally treated as unrelated. Metabolic state control addresses the shared root cause.
Research Papers
Published Essays
Evidence Base
21 cited studies organized across five research categories. Every claim linked to its primary source.
Scientific Framework
Figure 1. The Metabolic State Medicine therapeutic cascade: from metabolic inputs through systemic state change to disease modulation.
Research Network
Connect with researchers, clinicians, and scientists exploring metabolic state as a therapeutic variable. Shape the research agenda.